Cleveland Biolabs Inc. and Incuron Announce Poster Presentation at Cell Symposia: Cancer Epigenomics
Published: Oct 02, 2013
BUFFALO, N.Y., Oct. 2, 2013 (GLOBE NEWSWIRE) -- Cleveland BioLabs, Inc. (Nasdaq:CBLI) and Incuron, LLC, a joint venture between CBLI and Bioprocess Capital Ventures today announced a poster presentation at Cell Symposia: Cancer Epigenomics, to be held on October 6-8, 2013 in Meliá, Sitges, Spain.
Help employers find you! Check out all the jobs and post your resume.